GSK Net Income 2010-2023 | GSK
GSK annual/quarterly net income history and growth rate from 2010 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- GSK net income for the quarter ending March 31, 2023 was $1.810B, a 25.14% decline year-over-year.
- GSK net income for the twelve months ending March 31, 2023 was $17.891B, a 156.76% increase year-over-year.
- GSK annual net income for 2022 was $18.499B, a 206.79% increase from 2021.
- GSK annual net income for 2021 was $6.03B, a 18.31% decline from 2020.
- GSK annual net income for 2020 was $7.382B, a 24.46% increase from 2019.
GSK Annual Net Income
(Millions of US $) |
| 2022 |
$18,499 |
| 2021 |
$6,030 |
| 2020 |
$7,382 |
| 2019 |
$5,931 |
| 2018 |
$4,836 |
| 2017 |
$1,974 |
| 2016 |
$1,236 |
| 2015 |
$12,877 |
| 2014 |
$4,666 |
| 2013 |
$8,807 |
| 2012 |
$7,520 |
| 2011 |
$8,757 |
| 2010 |
$2,865 |
| 2009 |
$8,877 |
GSK Quarterly Net Income
(Millions of US $) |
| 2023-03-31 |
$1,810 |
| 2022-12-31 |
$2,880 |
| 2022-09-30 |
$12,149 |
| 2022-06-30 |
$1,052 |
| 2022-03-31 |
$2,418 |
| 2021-12-31 |
$990 |
| 2021-09-30 |
$1,611 |
| 2021-06-30 |
$1,950 |
| 2021-03-31 |
$1,480 |
| 2020-12-31 |
$962 |
| 2020-09-30 |
$1,607 |
| 2020-06-30 |
$2,808 |
| 2020-03-31 |
$2,005 |
| 2019-12-31 |
$1,697 |
| 2019-09-30 |
$1,914 |
| 2019-06-30 |
$1,239 |
| 2019-03-31 |
$1,081 |
| 2018-12-31 |
$1,325 |
| 2018-09-30 |
$1,848 |
| 2018-06-30 |
$600 |
| 2018-03-31 |
$1,063 |
| 2017-12-31 |
$-678 |
| 2017-09-30 |
$1,587 |
| 2017-06-30 |
$-230 |
| 2017-03-31 |
$1,296 |
| 2016-12-31 |
$319 |
| 2016-09-30 |
$1,061 |
| 2016-06-30 |
$-624 |
| 2016-03-31 |
$404 |
| 2015-12-31 |
$-541 |
| 2015-09-30 |
$834 |
| 2015-06-30 |
$228 |
| 2015-03-31 |
$12,248 |
| 2014-12-31 |
$1,556 |
| 2014-09-30 |
$648 |
| 2014-06-30 |
$1,114 |
| 2014-03-31 |
$1,123 |
| 2013-12-31 |
$3,924 |
| 2013-09-30 |
$1,566 |
| 2013-06-30 |
$1,605 |
| 2013-03-31 |
$1,466 |
| 2012-12-31 |
$1,370 |
| 2012-09-30 |
$1,807 |
| 2012-06-30 |
$1,981 |
| 2012-03-31 |
$2,139 |
| 2011-12-31 |
$1,972 |
| 2011-09-30 |
$2,191 |
| 2011-06-30 |
$1,802 |
| 2011-03-31 |
$2,442 |
| 2010-12-31 |
$-1,116 |
| 2010-09-30 |
$2,082 |
| 2010-06-30 |
$-427 |
| 2010-03-31 |
$2,056 |
| 2009-12-31 |
$2,724 |
| 2009-09-30 |
$2,251 |
| 2009-06-30 |
$2,262 |
| 2009-03-31 |
$1,681 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$69.839B |
$36.279B |
|
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
|
